Seeing Is Believing

Currently out of the existing stock ratings of Elliot Wilbur, 15 are a HOLD (12.71%), 103 are a BUY (87.29%).
Analyst Elliot Wilbur, carries an average stock price target met ratio of 53.17% that have a potential upside of 38% achieved within 513 days. Previously, Elliot Wilbur worked at RAYMOND JAMES, NEEDHAM.
Elliot Wilbur’s has documented 219 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on SLGL, Sol Gel Technologies Ltd at 11-Aug-2023.
Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS) at 11/7/2019. The price target of $4 was fulfilled within 26 days with a profit of $1.35 (50.94%) receiving and performance score of 19.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Jun-2020
4 years 5 months 12 days ago
(19-May-2022)
2/5 (40%)
$25.55 (57.48%)
136
Buy Since 16-Nov-2020
5 years 11 months 15 days ago
(16-Nov-2020)
0/3 (0%)
$1128.5 (658.02%)
Hold Since 26-Nov-2019
6 years 11 months 5 days ago
(26-Nov-2019)
1/1 (100%)
$-364 (-98.11%)
2030
Sell Since 23-Jul-2019
$77
7 years 3 months 8 days ago
(23-Jul-2019)
2/6 (33.33%)
$-12.6 (-14.06%)
9
$5
$4.51 (920.41%)
9 years 10 months 11 days ago
(20-Dec-2016)
1/1 (100%)
$-191 (-97.45%)
2327